The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients

SR-aGVHD remains a significant cause of morbidity and mortality in allogeneic HCT recipients. Alemtuzumab has been used with success in adult patients but has not been studied in the pediatric setting. To estimate the effectiveness of alemtuzumab for the treatment of SR-aGVHD in pediatric patients,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Khandelwal, Pooja, Lawrence, Julia, Filipovich, Alexandra H., Davies, Stella M., Bleesing, Jacob J., Jordan, Michael B., Mehta, Parinda, Jodele, Sonata, Grimley, Michael S., Kumar, Ashish, Myers, Kasiani, Marsh, Rebecca A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167786/
https://ncbi.nlm.nih.gov/pubmed/24384050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/petr.12183
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים